TAO Synergies (TAOX) Treasury Shares (2020 - 2026)
TAO Synergies' (TAOX) quarterly Treasury Shares came in at $11000.0 in Q2 2026, up 100.0% on a YoY basis from $5500.0 in Q2 2025, and little changed quarter-over-quarter from $11000.0 in Q1 2026.
Analysis
TAO Synergies (TAOX) Treasury Shares (2020 - 2026) Analysis & Trends
TAO Synergies (TAOX) has reported Treasury Shares for 6 consecutive years, with $11000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Treasury Shares rose 100.0% year-over-year to $11000.0; the trailing twelve-month figure through Jun 2026 stood at $11000.0 (up 100.0% YoY), and the FY2025 full-year result was $11000.0, up 156.71% from the prior year.
- Treasury Shares steadied at $11000.0 in Q2 2026 per TAOX's latest filing, from $11000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $6.8 million in Q3 2022 and bottomed at $1204.0 in Q3 2025.
- Historically, Treasury Shares has averaged $496480.6 across 5 years, with a median of $10000.0 in 2023.
- The sharpest annual moves came in 2023 and 2026: Treasury Shares tumbled 99.87% in 2023, then soared 208.12% in 2026.
- Over 5 years, Treasury Shares stood at $15000.0 in 2022, then plunged by 60.0% to $6000.0 in 2023, then slipped by 28.58% to $4285.0 in 2024, then jumped by 156.71% to $11000.0 in 2025, then changed by 0.0% to $11000.0 in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $11000.0, $11000.0, and $11000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.63 Bn | 197.64 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.39 Bn | 178.21 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.32 Bn | 124.47 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.47 Bn | 74.47 Bn | 3.93 Bn | 36.40 Mn |
| 5 | Argenx Se | 61.52 Bn | 56.34 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.79 Bn | 49.65 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.04 Bn | 30.73 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.39 Bn | 30.11 Bn | 1.96 Bn | -23.80 Mn |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn | - |
| 10 | TAO Synergies | 30.93 Mn | 30.93 Mn | - | 11,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11,000.00 |
| Jun 30, 2026 | 11,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 1,204.00 |
| Sep 30, 2025 | 1,204.00 |
| Jun 30, 2025 | 5,500.00 |
| Jun 30, 2025 | 5,500.00 |
| Mar 31, 2025 | 3,570.00 |
| Mar 31, 2025 | 3,570.00 |
| Dec 31, 2024 | 4,285.00 |
| Dec 31, 2024 | 4,285.00 |
| Mar 31, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Sep 30, 2023 | 9,000.00 |